Pathological and genomic phenotype of second neuroendocrine carcinoma during long-term follow-up after radical radiotherapy for nasopharyngeal carcinoma

BACKGROUND: Second head and neck neuroendocrine carcinoma (NEC) after radical radiotherapy for nasopharyngeal carcinoma (NPC) treatment is rarely reported. The prognosis of second cancer is poor, and our research focuses on finding a breakthrough in the treatment. In this study, we aimed to investig...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Ying-peng, Liu, Qiao-dan, Lin, Yu-jing, Peng, Shun-li, Wang, Rong, Xu, Xi-wei, Wei, Wei, Zhong, Gui-hua, Zhou, Yu-ling, Zhang, Ya-qin, Liu, Ye, Wang, Si-yang, Hong, Hai-yu, Liu, Zhi-gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504105/
https://www.ncbi.nlm.nih.gov/pubmed/34635145
http://dx.doi.org/10.1186/s13014-021-01898-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504105/
https://www.ncbi.nlm.nih.gov/pubmed/34635145
http://dx.doi.org/10.1186/s13014-021-01898-z

Ejemplares similares